United States · FDA National Drug Code directory
Ciprofloxacin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-2502_64c0aefd-0ce3-4ad3-b39c-8bcb910bd02e
- Product NDC
- 71335-2502
- Form
- TABLET
- Composition / generic term
- Ciprofolxacin
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20231001
- Source listing expiry
- 20261231
Source-listed ingredients
- CIPROFLOXACIN HYDROCHLORIDE — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 7 TABLET in 1 BOTTLE (71335-2502-0) · 71335-2502-0
- 20 TABLET in 1 BOTTLE (71335-2502-1) · 71335-2502-1
- 10 TABLET in 1 BOTTLE (71335-2502-2) · 71335-2502-2
- 14 TABLET in 1 BOTTLE (71335-2502-3) · 71335-2502-3
- 6 TABLET in 1 BOTTLE (71335-2502-4) · 71335-2502-4
- 30 TABLET in 1 BOTTLE (71335-2502-5) · 71335-2502-5
- 60 TABLET in 1 BOTTLE (71335-2502-6) · 71335-2502-6
- 12 TABLET in 1 BOTTLE (71335-2502-7) · 71335-2502-7
- 40 TABLET in 1 BOTTLE (71335-2502-8) · 71335-2502-8
- 90 TABLET in 1 BOTTLE (71335-2502-9) · 71335-2502-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →